Diffuse Midline Glioma (DMG): Clinical Trials

4 trials for Diffuse Midline Glioma (DMG), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 enrolling by invitation, 1 recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Not yet recruiting 2, Enrolling by invitation 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow Diffuse Midline Glioma (DMG): new trials by email Literature Review of Diffuse Midline Glioma (DMG) trials Research Report on Diffuse Midline Glioma (DMG)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response
LSAM-Cisplatin - Diffuse Midline Glioma (DMG), Diffuse Intrinsic Pontine Glioma (DIPG)
Phase 1 / Phase 2Not yet recruitingNanOlogy, LLC202026-12-012026-08-18
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
FZ-AD005 - High Grade Glioma (III or IV), Diffuse Midline Glioma (DMG)
Phase 1Not yet recruitingShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.402026-03-012026-03-06
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
Nivolumab, Azacitidine (AZA), lumbar puncture - Glioblastoma (GBM), Diffuse Midline Glioma (DMG)
Phase 1Enrolling by invitationAndrew P. Groves342025-06-052026-10-27
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
ONC206, Standard of Care Radiation Therapy, Optional Proton (1H) MR spectroscopy (MRS) - Diffuse Midline Glioma (DMG), Glioblastoma
Phase 1RecruitingSabine Mueller, MD, PhD2082021-08-232026-06-11

Narrower conditions

Glioblastoma (3)  ·  Astrocytoma (1)  ·  Central Nervous System Neoplasms (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Ependymoma (1)  ·  Glioma (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Germ Cell and Embryonal (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Neuroectodermal Tumors (4)  ·  Glioma (3)  ·  Astrocytoma (2)  ·  Neoplasms by Site (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Brain Diseases (1)  ·  Brain Neoplasms (1)  ·  Brain Stem Neoplasms (1)

Interventions

Azacitidine (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nivolumab (1)  ·  ONC206 (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Spinal Puncture (1)

Sponsors

Andrew P. Groves (1)  ·  NanOlogy, LLC (1)  ·  Sabine Mueller, MD, PhD (1)  ·  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1)

Countries

United States (2)  ·  China (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Sabine Mueller, MD, PhD (1)

Results publications

PMID 35157764, PMID 41256696

NIH funding

R01CA266596 (1)